While the mechanism of the negative association between GSTP1 and AFP in HCC patients is not defined, Zhu M et al. found that AFP could promote liver cancer stem cell initiation by activating the PI3K/Akt signal pathway [14]. The gene discussed is AFP; the disease is hepatocellular carcinoma.